India coronavirus vaccine candidate from Cadila Healthcare
SINGAPORE - Indian drug maker Cadila Healthcare is about to start a phase 3 clinical trial for a potential coronavirus vaccine, its chairman told CNBC."We are now entering the third phase, which will begin very, very soon," Pankaj Patel…